Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Functional Lung Avoidance SPECT-guided (ASPECT) Radiation Therapy for Lung Cancer Patients: Phase II Randomised Clinical Trial

NCT04676828 is registered in ClinicalTrials.gov with University of Aarhus as lead sponsor.

NCT NCT04676828
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04676828 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Functional Lung Avoidance SPECT-guided (ASPECT) Radiation Therapy for Lung Cancer Patients: Phase II Randomised Clinical Trial
Lead sponsor
University of Aarhus
Phase
Not applicable
Overall status
Recruiting
Start date
December 1, 2021
Completion date
December 1, 2028
Enrollment
90 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer, lung function decreased, pulmonary disease, radiation pneumonitis, radiation-induced disorder